{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:47:21Z","timestamp":1789163241956,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.msard.2019.101390","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:26:37Z","timestamp":1568719597000},"page":"101390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Epilepsy in multiple sclerosis as a network disease"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3789-6050","authenticated-orcid":false,"given":"Mihaela","family":"Bustuchina Vlaicu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.msard.2019.101390_bib0001","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1212\/WNL.0000000000004740","article-title":"Epilepsy in multiple sclerosis: a nationwide population-based register study","volume":"89","author":"Burman","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101390_bib0002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-008-0752-7","article-title":"Extensive cortical inflammation is associated with epilepsy in multiple sclerosis","volume":"255","author":"Calabrese","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2019.101390_bib0003","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(14)70101-2","article-title":"Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging","volume":"13","author":"Ciccarelli","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2019.101390_bib0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.seizure.2018.04.001","article-title":"Treatment of epilepsy in multiple sclerosis","volume":"58","author":"Dagiasi","year":"2018","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.msard.2019.101390_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.msard.2019.101390_bib0006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molimm.2012.12.009","article-title":"Leukocyte trafficking mechanisms in epilepsy","volume":"55","author":"Fabene","year":"2013","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2019.101390_bib0007","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10072-016-2803-7","article-title":"Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis","volume":"38","author":"Gasparini","year":"2017","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2019.101390_bib0008","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.5698\/1535-7597.18.1.12","article-title":"The epileptogenic zone: concept and definition","volume":"18","author":"Jehi","year":"2018","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.msard.2019.101390_bib0009","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1684\/j.1950-6945.2006.tb00206.x","article-title":"The Bancaud and Talairach view on the epileptogenic zone: a working hypothesis","volume":"8","author":"Kahane","year":"2006","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.msard.2019.101390_bib0010","doi-asserted-by":"crossref","first-page":"e00726","DOI":"10.1002\/brb3.726","article-title":"Unprovoked seizures in multiple sclerosis: why are they rare?","volume":"7","author":"Kav\u010di\u010d","year":"2017","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.msard.2019.101390_bib0011","article-title":"Treatment of seizures in multiple sclerosis","author":"Koch","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.msard.2019.101390_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroscience.2017.01.035","article-title":"Chronic demyelination-induced seizures","volume":"346","author":"Lapato","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.msard.2019.101390_bib0013","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1871527315666161104163031","article-title":"The sphingosine 1Phosphate signaling pathway in epilepsy: a possible role for the immunomodulator drug fingolimod in epilepsy treatment","volume":"16","author":"Leo","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.msard.2019.101390_bib0014","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnhum.2018.00138","article-title":"Disrupted module efficiency of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis","volume":"12","author":"Liu","year":"2018","journal-title":"Front Hum. Neurosci."},{"key":"10.1016\/j.msard.2019.101390_bib0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ane.12276","article-title":"Multiple sclerosis and seizures: incidence and prevalence over 40 years","volume":"130","author":"Lund","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2019.101390_bib0016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ane.12064","article-title":"Corticojuxtacortical involvement increases risk of epileptic seizures in multiple sclerosis","volume":"128","author":"Mart\u00ednez-Lapiscina","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2019.101390_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1352458515579445","article-title":"Temporal lobe cortical pathology and inhibitory gaba interneuron cell loss are associated with seizures in multiple sclerosis","volume":"22","author":"Nicholas","year":"2016","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2019.101390_bib0018","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5698\/1535-7597.18.2.95","article-title":"Is there a relationship between multiple sclerosis and epilepsy? if so what does it tell us about epileptogenesis?","volume":"18","author":"Pack","year":"2018","journal-title":"Epilepsy Curr."},{"issue":"12","key":"10.1016\/j.msard.2019.101390_bib0019","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.clinph.2010.05.017","article-title":"Brainstem lesions may be important in the development of epilepsy in multiple sclerosis patients: an evoked potential study","volume":"121","author":"Papathanasiou","year":"2010","journal-title":"Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.msard.2019.101390_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1684\/epd.2019.1083","article-title":"Antiepileptic drugs: evolution of our knowledge and changes in drug trials","volume":"21","author":"Perucca","year":"2019","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.msard.2019.101390_bib0021","first-page":"1","article-title":"Antiepileptogenic and anti-convulsive effects of fingolimod in experimental temporal lobe epilepsy","author":"Pitsch","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.msard.2019.101390_bib0022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hbm.21424","article-title":"Functional connectivity changes in multiple sclerosis patients: a graph analytical study of meg resting state data","volume":"34","author":"Schoonheim","year":"2013","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.msard.2019.101390_bib0023","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nicl.2018.07.012","article-title":"Magnetic resonance markers of tissue damage related to connectivity disruption in multiple sclerosis","volume":"20","author":"Solana","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.msard.2019.101390_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9678098","article-title":"Exploring the drug repurposing versatility of valproic acid as a multifunctional regulator of innate and adaptive immune cells","author":"Soria-Castro","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.msard.2019.101390_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1528-1157.2002.26901.x","article-title":"Neural networks in human epilepsy: evidence of and implications for treatment","volume":"43","author":"Spencer","year":"2002","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.msard.2019.101390_bib0026","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/17425255.2018.1421172","article-title":"Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs","volume":"14","author":"Stefanovi\u0107","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"6","key":"10.1016\/j.msard.2019.101390_bib0027","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/hbm.24020","article-title":"Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: an empirically informed modeling study","volume":"39","author":"Tewarie","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.msard.2019.101390_bib0028","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.neuroscience.2015.07.006","article-title":"Gray matter damage in multiple sclerosis: impact on clinical symptoms","volume":"303","author":"Van Munster","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.msard.2019.101390_bib0029","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.msard.2019.101390_bib0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejps.2013.04.014","article-title":"Glatiramer acetate, an anti-demyelination drug, reduced rats'epileptic seizures induced by pentylenetetrazol via protection of myelin sheath","volume":"49","author":"You","year":"2013","journal-title":"Eur. J. Pharm. Sciences"},{"issue":"4","key":"10.1016\/j.msard.2019.101390_bib0031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819303700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819303700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:46:58Z","timestamp":1761900418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819303700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":31,"alternative-id":["S2211034819303700"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.101390","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy in multiple sclerosis as a network disease","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.101390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101390"}}